Ocugen is a biotechnology company pioneering gene therapies and vaccines for ocular diseases and respiratory infections. It focuses on developing treatments for blindness-causing conditions like retinitis pigmentosa and wet AMD, alongside a COVID-19 vaccine. Patients with inherited retinal diseases and public health communities benefit from its innovative, accessible medical solutions.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends